Publication | Open Access
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
88
Citations
49
References
2020
Year
LGR5 has distinct roles in ER<sup>-</sup> vs. ER<sup>+</sup> BC with potential clinical applicability as a biomarker to identify patients in need of therapy and could serve as a therapeutic target for high-grade ER<sup>-</sup> BC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1